Abstract. In the context of the COBRAS/SAMBA mission study 1 , we discuss in-flight calibration of extended sky maps of the microwave sky using celestial sources. We simulate the observations in order to assess the accuracy obtainable for absolute and relative calibration of the Low Frequency Instrument (LFI), operating in the 30 − 130 GHz range. Accurate calibration can be achieved using the CMB dipole signal, ∆T D . With conservative assumptions on the effect of Galactic contamination, we find that the CMB dipole will provide absolute calibration accuracy ∼ 0.7% (limited by the COBE-DMR uncertainty on ∆T D ) on time-scales of about 10 days at all frequencies and for the entire mission lifetime. Long-term calibration with accuracy < 0.2% can be obtained using the spacecraft orbital velocity. Additional, independent calibration will be provided by the observation of external planets. We also describe the capability of the proposed scanning technique to detect and remove long-term instrumental drifts, and show that these effects, if present, can be controlled and removed with an overall negligible impact on the data uncertainty.
We study tilted cold dark matter (CDM) models, that is OMEGA0 = 1 models with a primordial spectral index n less than or similar to 1. We test these models against three experiments on the cosmic microwave background anisotropy at 7', 3-degrees, and 6-degrees, and against measurements of galaxy peculiar velocities on large scales. These observations together suggest that the whole class of tilted CDM models with n less-than-or-equal-to 1 can be ruled out, for any value of the biasing parameter b
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.